Skip navigation
Skip navigation

Breast cancer risk in relation to the interval between menopause and starting hormone therapy

Beral, Valerie; Reeves, Gillian K; Bull, Diana; Green, Jane; Million Women Study, Collaborators; Banks, Emily

Description

Background: Although breast cancer risk is greater in users of estrogen-progestin than estrogen-only formulations of menopausal hormonal therapy, reports on their effects have been somewhat inconsistent. We investigated whether the timing of these therapies affected breast cancer incidence. Methods: A total of 1 129 025 postmenopausal UK women provided prospective information on hormonal therapy use and other factors relevant for breast cancer risk. We used Cox regression to estimate adjusted...[Show more]

CollectionsANU Research Publications
Date published: 2011
Type: Journal article
URI: http://hdl.handle.net/1885/54637
Source: Journal of the National Cancer Institute
DOI: 10.1093/jnci/djq527

Download

File Description SizeFormat Image
01_Beral_Breast_cancer_risk_in_relation_2011.pdf439.6 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator